Benzphetamine tablets, 50mg, CIII, repackaged in 30-count bottles, Distributed by Calvin Scott & ...
FDA Drug Recall #D-1123-2022 — Class III — January 15, 2021
Recall Summary
| Recall Number | D-1123-2022 |
| Classification | Class III — Low risk |
| Date Initiated | January 15, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Calvin Scott & Company, Inc. |
| Location | Albuquerque, NM |
| Product Type | Drugs |
| Quantity | 13 bottles |
Product Description
Benzphetamine tablets, 50mg, CIII, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 10702-0040-50
Reason for Recall
Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.
Distribution Pattern
1 physician in Alpharetta, GA
Lot / Code Information
CSI Lot: CS-20274-005, Exp 5/22
Other Recalls from Calvin Scott & Company, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1124-2022 | Class I | Benzonatate capsules, 100mg, repackaged in 30-c... | Jan 15, 2021 |
| D-0009-2021 | Class II | Diethylpropion, 25 mg tablets, Rx only, Distrib... | Sep 16, 2020 |
| D-0010-2021 | Class II | Diethylpropion, 75 mg tablets, Rx only, Distrib... | Sep 16, 2020 |
| D-0011-2021 | Class II | Phentermine, 30 mg capsules, Rx only, Distribut... | Sep 16, 2020 |
| D-1525-2020 | Class II | Phentermine 15mg grey/Yellow Capsules, 28-count... | Jul 27, 2020 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.